Tenax Therapeutics, Inc. is a specialty pharmaceutical firm focused on the advancement of innovative therapies for cardiovascular and pulmonary diseases, catering primarily to the U.S. and Canadian markets. Headquartered in Morrisville, North Carolina, the company aims to address unmet medical needs through its proprietary drug development pipeline, which includes products aimed at improving patient outcomes in critical care settings. With a commitment to enhancing treatment options in the cardiovascular and pulmonary sectors, Tenax Therapeutics is poised for growth as it leverages its expertise and research capabilities to bring novel therapeutics to market.